Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancer

BACKGROUND: Indoleamine 2,3-dioxygenase 1 (IDO1) is an enzyme with immunomodulatory properties that has emerged as a potential immunotherapeutic target in human cancer. However, the role, expression pattern, and relevance of IDO1 in esophageal cancer (EC) are poorly understood. Here, we utilize gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenberg, Ari J., Wainwright, Derek A., Rademaker, Alfred, Galvez, Carlos, Genet, Matthew, Zhai, Lijie, Lauing, Kristen L., Mulcahy, Mary F., Hayes, John P., Odell, David D., Horbinski, Craig, Komanduri, Srinadh, Tetreault, Marie-Pier, Kim, Kwang-Youn A., Villaflor, Victoria M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955099/
https://www.ncbi.nlm.nih.gov/pubmed/29805749
http://dx.doi.org/10.18632/oncotarget.25235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955099/
https://www.ncbi.nlm.nih.gov/pubmed/29805749
http://dx.doi.org/10.18632/oncotarget.25235

Ejemplares similares